Yüklüyor......
Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Korean Diabetes Association
2011
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3122893/ https://ncbi.nlm.nih.gov/pubmed/21738898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.159 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|